| RPRX Average Annual Return Chart Since 2020 | |||
Also see: • RPRX stock yearly return 2020 • RPRX stock yearly return 2021 • RPRX stock yearly return 2022 • RPRX stock yearly return 2023 • RPRX YTD return | |||
| Average Annual Return Benchmarks |
|
Compare RPRX average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| RPRX Share Performance |
| RPRX Average Annual Return Table Since 2020 | |||||||||||||||||||||||||||||||||
RPRX average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| About Royalty Pharma plc |
| Royalty Pharma is a buyer of biopharmaceutical royalties. The royalties in Co.'s marketed portfolio related to approved products include: cystic fibrosis franchise, which consists of Co.'s right to receive royalty payments on the sale of various products for use in the treatment of cystic fibrosis, including Kalydeco (ivacaftor), Orkambi (lumacaftor and ivacaftor), Symdeko/Symkevi (tezacaftor and ivacaftor) and Trikafta/Kaftrio (elexacaftor, tezacaftor and ivacaftor); and Tysabri, which is a monoclonal antibody for the treatment of relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease. The RPRX average annual return since 2020 is shown above.
The Average Annual Return on the RPRX average annual return since 2020 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends. Thus, researching Average Annual Returns is good practice for investors — whether RPRX average annual return since 2020 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the RPRX average annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| RPRX Current Stock Quote |
 Free RPRX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Average Annual Return! | |
|
| Average Annual Return Peers |
| Royalty Pharma (RPRX) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
RSLS Average Annual Return |
Video: Don't Forget Dividends in Average Annual Return!